Thursday, September 10, 2020, from 4:00-5:00 pm Eastern Time PRINCETON, N.J., Sept. 3, 2020 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it will… Read More..
Earnings Call Scheduled for 8:00 am ET on September 10, 2020 SAN JOSE, Calif., Aug. 28, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States announced today that it has rescheduled… Read More..
KELOWNA, BC / ACCESSWIRE / August 31, 2020 / Lexaria Bioscience Corp. (OTCQX:LXRP)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that it has entered a research and development ("R&D") framework agreement with British American Tobacco (Investments) Limited ("BAT") to investigate Lexaria's technology for potential use… Read More..